• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
CXSL1700027 重组人-鼠嵌合抗CD20单克隆抗体注射液 rituximab Injection Biological Products(2) New Drug Application 2017-07-13 喜康(武汉)生物医药有限公司 Xikang(Wuhan)Biopharmaceutical Co Ltd Certificate Issued 2018-06-28 view
CXSL1900083 注射用重组人源化抗HER2单克隆抗体 Recombinant humanized monoclonal antibody against HER2 Lyophilized Biological Products(2) New Drug Application 2019-08-06 喜康(武汉)生物医药有限公司 Xikang(Wuhan)Biopharmaceutical Co Ltd In Review 2019-08-05 view
CXSL1800037 重组人源化抗VEGF单克隆抗体注射液 Injection Biological Products(2) New Drug Application 2018-04-19 喜康(武汉)生物医药有限公司 Xikang(Wuhan)Biopharmaceutical Co Ltd Certificate Issued 2018-09-25 view